Precigen Ownership | Who Owns Precigen?

Overview Forecast RevenueFinancials Chart Transcripts

Precigen Ownership Summary

Precigen is owned by 14.15% institutional investors, 13.63% insiders, and 72.23% retail investors. Patient capital management is the largest institutional shareholder, holding 5.69% of PGEN shares. Patient Opportunity C is the top mutual fund, with 3.64% of its assets in Precigen shares.

PGEN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Precigen	14.15%	13.63%	72.23%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Patient capital management	17.82M	5.69%	$68.95M
Blackrock funding, inc. /de	15.22M	4.86%	$58.91M
Blackrock	10.25M	4.11%	$16.19M
Vanguard group	10.48M	3.54%	$43.80M
State street	10.89M	3.48%	$42.14M
Diametric capital, lp	6.80M	2.17%	$26.32M
Point72 asset management	6.64M	2.12%	$25.71M
Tang capital management	6.42M	2.05%	$24.84M
Geode capital management	4.61M	1.47%	$17.86M
Iridian asset management llc/ct	3.59M	1.15%	$13.90M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Diametric capital, lp	6.80M	6.84%	$26.32M
Iridian asset management llc/ct	3.59M	5.64%	$13.90M
Patient capital management	17.82M	2.52%	$68.95M
Boxer capital management	3.50M	1.78%	$13.54M
Tang capital management	6.42M	1.26%	$24.84M
Emfo	519.48K	0.73%	$820.77K
Lansing street advisors	553.66K	0.54%	$2.14M
Prelude capital management	1.27M	0.38%	$4.92M
Lexaurum advisors	689.41K	0.35%	$2.67M
Bayesian capital management, lp	39.60K	0.19%	$153.25K

Top Buyers

Holder	Shares	% Assets	Change
Diametric capital, lp	6.80M	6.84%	2.95M
Franklin resources	2.63M	0.00%	2.17M
Boxer capital management	3.50M	1.78%	2.13M
Jane street group	1.82M	0.00%	1.82M
Vanguard group	10.48M	0.00%	1.54M

Top Sellers

Holder	Shares	% Assets	Change
Point72 asset management	6.64M	0.03%	-7.08M
Driehaus capital management	793.77K	0.02%	-2.81M
Fmr	2.00M	0.00%	-2.65M
Parkman healthcare partners	-	-	-1.00M
Opaleye management	-	-	-947.50K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	1.20M	0.00%	1.20M	$4.64M
Hrt financial lp	710.78K	0.01%	710.78K	$2.75M
Lexaurum advisors	689.41K	0.35%	689.41K	$2.67M
Arrowstreet capital, limited partnership	395.69K	0.00%	395.69K	$1.53M
Kbc group nv	345.81K	0.00%	345.81K	$1.34M

Sold Out

Holder	Change
Capital performance advisors llp	-2.00
Pnc financial services group	-19.00
True wealth design	-20.00
Srs capital advisors	-46.00
Financial consulate	-70.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	118	-35.87%	44,277,448	-67.44%	14	0.67%	61	-45.05%	23	-36.11%
Dec 31, 2025	113	-35.80%	67,502,683	-39.35%	22	1.62%	69	-26.60%	19	-52.50%
Sep 30, 2025	170	15.65%	111,283,863	41.15%	37	5.31%	91	42.19%	38	15.15%
Jun 30, 2025	148	4.23%	81,957,215	2.59%	27	3.30%	64	6.67%	34	-17.07%
Mar 31, 2025	141	6.01%	79,994,349	5.56%	28	3.84%	58	-10.77%	42	44.83%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Patient Opportunity C	12.90M	3.64%	-1.12M
State Street® SPDR® S&P® Biotech ETF	6.69M	1.88%	-66.13K
Vanguard US Total Market Shares ETF	5.45M	1.85%	-
Vanguard Total Stock Mkt Idx Inv	5.00M	1.40%	-
iShares Russell 2000 ETF	4.26M	1.20%	35.91K
Vanguard Institutional Extnd Mkt Idx Tr	1.99M	0.56%	10.31K
Fidelity Small Cap Growth	1.80M	0.50%	-563.80K
Fidelity Small Cap Index	1.76M	0.49%	15.74K
Heptagon Driehaus US Micro Cap Eq C$ Acc	1.73M	0.49%	307.87K
iShares Russell 2000 Growth ETF	1.38M	0.39%	3.57K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 28, 2026	Thomasian Harry Jr.	Chief Financial Officer	Sell	$182.61K
May 28, 2026	Tennant Phil	Chief Commercial Officer	Sell	$131.99K
May 28, 2026	Shah Rutul R	Chief Operating Officer	Sell	$186.19K
May 28, 2026	Lehr Donald P.	Chief Legal Officer	Sell	$127.01K
May 28, 2026	Sabzevari Helen	President and CEO	Sell	$519.93K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2026 Q1	-	11
2025 Q4	-	15
2025 Q3	7	5
2025 Q2	-	-

PGEN Ownership FAQ

Who Owns Precigen?

Precigen shareholders are primarily institutional investors at 14.15%, followed by 13.63% insiders and 72.22% retail investors. The average institutional ownership in Precigen's industry, Biotech Stocks , is 35.75%, which Precigen falls below.

Who owns the most shares of Precigen?

Precigen’s largest shareholders are Patient capital management (17.82M shares, 5.69%), Blackrock funding, inc. /de (15.22M shares, 4.86%), and Blackrock (10.25M shares, 4.11%). Together, they hold 14.67% of Precigen’s total shares outstanding.

Does Blackrock own Precigen?

Yes, BlackRock owns 4.11% of Precigen, totaling 10.25M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 16.19M$. In the last quarter, BlackRock decreased its holdings by -116K shares, a -1.12% change.

Who is Precigen’s biggest shareholder by percentage of total assets invested?

Diametric capital, lp is Precigen’s biggest shareholder by percentage of total assets invested, with 6.84% of its assets in 6.8M Precigen shares, valued at 26.32M$.

Who is the top mutual fund holder of Precigen shares?

Patient Opportunity C is the top mutual fund holder of Precigen shares, with 3.64% of its total shares outstanding invested in 12.9M Precigen shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools